AbioKin - Antibiotic Kinetics

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Critical IllnessInfection
Interventions
DRUG

Linezolid

Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.

DRUG

Meropenem

Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.

DRUG

Piperacillin-tazobactam combination product

Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.

DRUG

Vancomycin

Drug choice is performed according to standard clinical practice, that will not be modified by the participation in the study. As a consequence, assignment of patients to groups is not protocol based, but it is defined by standard clinical choices.

Trial Locations (11)

10148

Ospedale San Giovanni Bosco, Servizio Anestesia e Rianimazione B-DEA, Turin

23807

"Presidio Ospedaliero San Leopoldo Mandic", Merate

23900

Ospedale A. Manzoni, U.O. Anestesia e Rianimazione 1, Lecco

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

40133

Ospedale Maggiore, C.A. Pizzardi, Bologna

47023

Ospedale Maurizio Bufalini, UO Anestesia Terapia Intensiva, Cesena

50032

Ospedale del Mugello, Borgo San Lorenzo

50122

Ospedale Santa Maria Nuova, Anestesia e Rianimazione, Florence

50143

Ospedale S. Giovanni di Dio ASL 10, Servizio Anestesia e Rianimazione, Florence

58016

Ospedale San Giovanni di Dio, Orbetello

Ospedale Misericordia, Grosseto

All Listed Sponsors
lead

Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva

OTHER

NCT02609646 - AbioKin - Antibiotic Kinetics | Biotech Hunter | Biotech Hunter